A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F(2α) on retinal vessels

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 5 43-5, 1998, Pages

  Lahaie, Isabelle ^a   Hardy, Pierre ^a   Hou, Xin ^a   Hasséssian, Haroutioun ^b   Asselin, Pierre ^a   Lachapelle, Pierre ^c   Almazan, Guillermina ^d   Varma, Daya R ^d   Morrow, Jason D ^e   Jackson Roberts II, L ^e   Chemtob, Sylvain ^a,d  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

Calcium influx; Cyclooxygenase; Endothelin; Peroxidation; Thromboxane

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 METHYL 2 (3 PYRIDYL) 1 INDOLEOCTANOIC ACID; 6,8 DIFLUORO 1,2,3,4 TETRAHYDRO 9 (4 METHYLSULFONYLBENZYL)CARBAZOLE 1 ACETIC ACID; CALCIUM; ENDOTHELIN; ENDOTHELIN CONVERTING ENZYME; NIFEDIPINE; PHOSPHORAMIDON; PROSTAGLANDIN F1 ALPHA; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOXIA; ARTICLE; CALCIUM TRANSPORT; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; RETINA BLOOD VESSEL; SMOOTH MUSCLE FIBER; SWINE; VASOCONSTRICTION;

EID: 0031804251     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.5.r1406     Document Type: Article

References (56)

1. Abran, D., P. Hardy, D. R. Varma, and S. Chemtob. Mechanisms of the biphasic effects of peroxides on the retinal vasculature of newborn and adult pigs. Exp. Eye Res. 61: 285-292, 1995.
2. 2α receptors on the retinal vasculature of the pig. Prostaglandins 50: 253-267, 1995.
3. Abran, D., D. R. Varma, and S. Chemtob. Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H628-H632, 1995.
4. Abran, D., D. R. Varma, D. Y. Li, and S. Chemtob. Reduced responses of retinal vessels of the newborn pig to prostaglandins but not to thromboxane. Can. J. Physiol. Pharmacol. 72: 168-173, 1994.
5. Ambler, J., K. D. Butler, E. C. Ku, E. D. Maguire, J. R. Smith, and R. B. Wallis. CGS 12970: a novel, long acting thromboxane synthetase inhibitor. Br. J. Pharmacol. 86: 497-504, 1985.
6. Aveldaño, M. I., and N. G. Bazan. Free fatty acids, diacyl- and triacylglycerols and total phospholipids in vertebrate retina: comparison with brain, choroid and plasma. J. Neurochem. 23: 1127-1135, 1974.
7. 2α, in rabbit lung in situ. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H660-H663, 1992.
8. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
9. Chemtob, S., P. Hardy, D. Abran, D.-Y. Li, K. Peri, O. Cuzzani, and D. R. Varma. Peroxide cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics. J. Appl. Physiol. 78: 2039-2046, 1995.
10. De Keulenaer, G. W., L. J. Andries, S. U. Sys, and D. L. Brutsaert. Endothelin-mediated positive inotropic effect induced by reactive oxygen species in isolated cardiac muscle. Circ. Res. 76: 878-884, 1995.
11. 2+-flux pathways in canine venous endothelial cells. Biochem. J. 297: 209-215, 1994.
12. Ford-Hutchinson, A. W., Y. Girard, A. Lord, T. R. Jones, M. Cirino, J. F. Evans, J. Gillard, P. Hamel, C. Leveillé, P. Masson, and R. Young. The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist. Can. J. Physiol. Pharmacol. 67: 989-993, 1989.
13. 2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 264 (Cell Physiol. 33): C1619-C1624, 1993.
14. 2-isoprostane, on endothelin-1 release. J. Cardiovasc. Pharmacol. 26, Suppl. 3: S51-S52, 1995.
15. Godfraind, T. Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries. J. Pharmacol. Exp. Ther. 224: 443-450, 1983.
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
17. Hanna, N., K. G. Peri, D. Abran, P. Hardy, A. Doke, P. Lachapelle, M.-S. Roy, J. Orquin, D. R. Varma, and S. Chemtob. Light induces peroxidation in retina by activating prostaglandin G/H synthase. Free Radic. Biol. Med. 23: 885-897, 1997.
18. Hardy, P., D. Abran, D.-Y. Li, H. Fernandez, D. R. Varma, and S. Chemtob. Free radicals in retinal and choroidal blood flow autoregulation in the piglet: interaction with prostaglandins. Invest. Ophthalmol. Vis. Sci. 35: 580-591, 1994.
19. Himmel, H. M., A. R. Whorton, and H. C. Strauss. Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. Hypertension 21: 112-127, 1993.
20. Hockerman, G. H., B. Z. Peterson, B. D. Johnson, and W. A. Catterall. Molecular determinants of drug binding and action on L-type calcium channels. Annu. Rev. Pharmacol. Toxicol. 37: 361-396, 1997.
21. Hoffman, S. W., S. Moore, and E. F. Ellis. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke 28: 844-849, 1997.
22. Hughes, A. D. Calcium channels in vascular smooth muscle cells. J. Vasc. Res. 32: 353-370, 1995.
23. Hyslop, S., and G. De Nucci. Prostaglandin biosynthesis in the microcirculation: regulation by endothelial and non-endothelial factors. Prostaglandins Leukot. Essent. Fatty Acids 49: 723-760, 1993.
24. A receptor. Life Sci. 50: 247-255, 1992.
25. Ishikawa, K., M. Ihara, K. Noguchi, T. Mase, N. Mino, T. Saeki, T. Fukuroda, T. Fukami, S. Ozaki, T. Nagase, M. Nishikibe, and M. Yano. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA 91: 4892-4896, 1994.
26. 2α in isolated perfused rat lung. J. Appl. Physiol. 74: 460-465, 1993.
27. 2α. Br. J. Pharmacol. 119: 1276-1280, 1996.
28. Kruse, H. J., B. Grunberg, W. Siess, and P. C. Weber. Formation of biologically active autacoids is regulated by calcium influx in endothelial cells. Arterioscler. Thromb. 14: 1821-1828, 1994.
29. 2 effects on cerebral prostanoids and pial arteriolar diameter in piglets. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H1382-H1387, 1990.
30. Leffler, C. W., R. Mirro, W. M. Armstead, D. W. Busija, and O. Thelin. Prostanoid synthesis and vascular responses to exogenous arachidonic acid following cerebral ischemia in piglets. Prostaglandins 40: 241-248, 1990.
31. 2 receptors, their second messengers and vasoconstrictor response to adult levels. J. Pharmacol. Exp. Ther. 278: 370-377, 1996.
32. 2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem. Pharmacol. 47: 1173-1177, 1994.
33. 2+ permeability of unstimulated rat lymphocytes. J. Biol. Chem. 266: 10872-10879, 1991.
34. Merritt, J. E., W. P. Armstrong, C. D. Benham, T. J. Hallam, R. Jacob, A. Jaxa-Chamiec, B. K. Eigh, S. A. McCarthy, K. E. Moores, and T. J. Rink. SK&F96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J. 271: 515-522, 1990.
35. Moreno, A., J. P. De La Cruz, F. Merida, J. Garcia Campos, and F. Sanchez De La Cuesta. Effects of ditazol on the vascular retinal pattern in experimental diabetes in rats. Haemostasis 25: 166-171, 1995.
36. 2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA 89: 10721-10725, 1992.
37. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J. Clin. Invest. 90: 2502-2507, 1992.
38. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87: 9383-9387, 1990.
39. 2α, is formed in vivo. Biochim. Biophys. Acta 1210: 244-248, 1994.
40. Morrow, J. D., and L. J. Roberts II. The isoprostanes: current knowledge and directions for future research. Biochem. Pharmacol. 51: 1-9, 1996.
41. Morrow, J. D., and L. J. Roberts II. Generation and actions of isoprostanes. Biochim. Biophys. Acta 1345: 121-135, 1997.
42. Penn, J. S., L. A. Thum, and M. I. Naash. Oxygen-induced retinopathy in the rat. Vitamins C and E as potential therapies. Invest. Ophthalmol. Vis. Sci. 33: 1836-1845, 1992.
43. 2α is not mediated by thromboxane receptor isoforms. J. Biol. Chem. 271: 14916-14924, 1996.
44. 2 receptor in the vasoconstrictor response of rat aorta to endothelin. J. Pharmacol. Exp. Ther. 252: 915-921, 1990.
45. Robertson, P. L., D. Ar, and G. W. Goldstein. Phosphoinositide metabolism and prostacyclin formation in retinal microvascular endothelium: stimulation by adenine nucleotides. Exp. Eye Res. 50: 37-44, 1990.
46. 2-isoprostane production and cytolysis in renal tubular epithelial cells. J. Am. Soc. Nephrol 6: 1300-1303, 1995.
47. Setty, B. N. Y., D. L. Phelps, R. W. Walenga, and M. J. Stuart. Identification of prostaglandins and hydroxyeicosatetraenoic acids in kitten retina: comparison with other species. Exp. Eye Res. 53: 81-88, 1991.
48. Sokal, R. R., and F. J. Rohlf. Comparison among means. In: Biometry, edited by R. R. Sokal and F. J. Rohlf. New York: Freeman, 1981, p. 232-262.
49. Southorn, P. A., and G. Powis. Free radicals in medicine. I. Chemical nature and biological reactions. II. Involvement in human disease. Mayo Clin. Proc. 63: 381-408, 1988.
50. 2 receptors. J. Clin. Invest. 90: 136-141, 1992.
51. Tate, R. M., H. G. Morris, W. R. Schroeder, and J. E. Repine. Oxygen metabolites stimulate thromboxane production and vaso-constriction in isolated saline-perfused rabbit lungs. J. Clin. Invest. 74: 608-613, 1984.
52. Tesfamarian, B. Free radicals in diabetic endothelial cell dysfunction. Free Radic. Biol. Med. 16: 383-391, 1994.
53. Turner, A. J., and L. J. Murphy. Molecular pharmacology of endothelin-converting enzymes. Biochem. Pharmacol. 51: 91-102, 1996.
54. 2α in rat aortic rings. Prostaglandins 54: 581-599, 1997.
55. Yagi, K., S. Matsuoka, H. Ohkawa, N. Ohishi, Y. Takevchi, and H. Kakai. Lipoperoxide level of the retina of the chick embryo exposed to high concentration of oxygen. Clin. Chim. Acta 80: 355-360, 1977.
56. 2. Adv. Prostaglandin Thromboxane Leukotr. Res. 23: 237-239, 1995.